Ahmed Hamdy
Researcher Next ID · RN-013382
Researcher · Medicine
Research Institute for Tropical Medicine
, Philippines
- Works count
- 156
- Citation count
- 6,528
- H-index
- 25
- i10-index
- 38
Research interests
Publications
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Journal of Clinical Oncology · 2021 · 10.1200/jco.21.01210
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2015 · 10.1056/nejmoa1509981
Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
The Lancet Oncology · 2013 · 10.1016/s1470-2045(13)70513-8
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
Journal of Clinical Oncology · 2012 · 10.1200/jco.2012.42.7906
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Blood · 2011 · 10.1182/blood-2011-01-328484
Current projects
No projects listed.